4
Changes in Ownership
Attovia Therapeutics, Inc. Filed Acc 0000905148-26-003548
10% owner bought 382,352 shares at $17.00 ($6,499,984)
- 10% owner acquired 3,799,015 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| venBio Global Strategic Fund IV, L.P. 10% owner | 2026-08-06 | Conversion | +2,311,870 | 2,311,870 | D | ||
| venBio Global Strategic Fund IV, L.P. 10% owner | 2026-08-06 | Conversion | +821,998 | 3,133,868 | D | ||
| venBio Global Strategic Fund IV, L.P. 10% owner | 2026-08-06 | Conversion | +665,147 | 3,799,015 | D | ||
| venBio Global Strategic Fund IV, L.P. 10% owner | 2026-08-06 | Purchase | +382,352 | $17.00 | $6,499,984 | 4,181,367 | D |
| Derivatives | |||||||
| venBio Global Strategic Fund IV, L.P. 10% owner | 2026-08-06 | Conversion · Series A Preferred Stock | −21,477,273 | 0 | D | ||
| venBio Global Strategic Fund IV, L.P. 10% owner | 2026-08-06 | Conversion · Series B Preferred Stock | −7,636,362 | 0 | D | ||
| venBio Global Strategic Fund IV, L.P. 10% owner | 2026-08-06 | Conversion · Series C Preferred Stock | −6,179,219 | 0 | D | ||
| Open-market purchases · 382,352 sh · avg $17.00 · $6,499,984 | |||||||
Loading xslF345X06/form4.xml…